Search

everythinglearnresearchcommunity

for

Search:↓

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Biomedical imaging has greatly improved understanding and treatment of solid tumors.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

HT-scCAT-seq helps understand gene regulation in embryonic skin development.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

Genetic mutations cause various hair diseases, and whole genome sequencing may reveal more about these conditions.

Blocking mTORC1 reduces skin tumor growth in mice.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Low-penetration genes might help personalize colorectal cancer prevention.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

The study concluded that genetic mutations affect human hair diseases and identified key genes and pathways involved in hair growth and cycling.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Two new gene mutations cause a rare hair disorder.

Key genes linked to hair growth and cancer were identified in hairless mice.

PTCH gene mutations contribute to basal cell carcinoma development.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.